Release Date: 09/06/09 09:11 Summary: Omacetaxine Shows Activity in Refractory CML Price Sensitive: Yes Download Document 45.64KB Download
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress